Zobrazeno 1 - 10
of 19
pro vyhledávání: '"G. L. Bartels"'
Autor:
J. L. Posma, Y. Plantinga, D. Rinkes, Robert G. Tieleman, C. Hofman, R. Cator, G. L. Bartels, R. Houben
Publikováno v:
Europace
EP Europace, 16(9), 1291-1295. Oxford University Press
EP Europace, 16(9), 1291-1295. Oxford University Press
Patients with asymptomatic and undiagnosed atrial fibrillation (AF) are at increased risk of heart failure and ischaemic stroke. In this study, we validated a new diagnostic device, the MyDiagnostick, for detection of AF by general practitioners and
Autor:
Femke Waanders, W. M. T. Janssen, K. E. Broekman, G. L. Bartels, Gerarda Navis, Steef J. Sinkeler
Publikováno v:
Heart failure reviews, 19(6), 709-716. SPRINGER
Chronic congestive heart failure (HF) has a rising prevalence and increasing impact on health care systems. Current treatment consists of diuretics, renin-angiotensin-aldosterone system blockers, and restriction of salt and fluids. This strategy is o
Publikováno v:
European Heart Journal, 20(23), 1717-1723. Oxford University Press
textabstractAIMS: In patients with coronary artery disease acetylcholine (a muscarinic agonist) causes vasoconstriction. The effect of atropine (a muscarinic antagonist) on coronary vasotone in patients with normal or impaired left ventricular functi
Autor:
W. J. Remme, Afm van den Heuvel, Dacm Kruijssen, van Dirk Veldhuisen, G. L. Bartels, M. van der Ent
Publikováno v:
Journal of Cardiovascular Pharmacology. 31:506-512
Recently, different beta-blockers have been shown to be effective in the treatment of chronic heart failure (CHF), but the importance of their ancillary properties is not clear. Epanolol is a selective beta1-blocker with intrinsic sympathomimetic act
Publikováno v:
Cardiovascular Drugs and Therapy. 12:395-403
Treatment of patients with severe heart failure by ACE inhibition is often limited by worsening of renal function. To evaluate whether trandolapril, a potent lipophilic ACE inhibitor, affects renal function in severe heart failure, we studied 12 pati
Autor:
X. H. Krauss, W. J. Remme, M. van der Ent, D. C. A. van Hoogenhuyze, Dick A.C.M. Kruijssen, G. L. Bartels
Publikováno v:
Cardiology. 88:548-555
Although several large studies indicate a beneficial effect of angiotensin-converting enzyme (ACE) inhibitors after myocardial infarction, the optimal timing of therapy in terms of safety and the effects on neurohormones during myocardial infarction
Publikováno v:
Cardiovascular Drugs and Therapy. 9:749-753
Cardiac L-carnitine content, essential for mitochondrial fatty acid transport and ATP-ADP exchange, decreases during ischemia. In animal models, administration of the natural derivative, L-propionylcarnitine, may reduce ischemia and improve cardiac f
Autor:
W. J. Remme, G. L. Bartels
Publikováno v:
European Heart Journal. 16:87-95
ACE inhibitors have the potential to affect myocardial ischaemia in patients with asymptomatic ventricular dysfunction and ischaemic cardiomyopathy after long-term treatment. However, anti-ischaemic effects are virtually absent in stable effort angin
Autor:
Dirk J. Duncker, L. M. A. Sassen, Jos M. J. Lamers, Rob Krams, J. R. Van Meegen, Pieter D. Verdouw, Edward O McFalls, G. L. Bartels, Karel Bezstarosti
Publikováno v:
Journal of Cardiovascular Pharmacology. 22:488-498
In postischemic myocardium, fatty acid oxidation may be deficient owing to depletion of carnitine and citric acid cycle intermediates and fatty acylCoA-induced inhibition of adenine nucleotide translocase. During postischemic stress, the impairment o
Publikováno v:
Journal of Cardiovascular Pharmacology. 22:327-335
Acute systemic and, possibly, coronary vasoconstriction may limit the usefulness of i.v. beta-blockade for the management of hypertension in ischemic patients. The acute hemodynamic and neurohumoral profile of i.v. dilevalol (50 mg/5 min), a nonselec